These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16765499

  • 1. Subjective response to neuroleptics: the effect of a questionnaire about neuroleptic side effects.
    Taira M, Hashimoto T, Takamatsu T, Maeda K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1139-42. PubMed ID: 16765499
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M, Togo T, Yoshimi A, Fujita J, Nomoto M, Kamijo A, Amagai T, Uchikado H, Katsuse O, Hosojima H, Sakura Y, Furusho R, Suda A, Yamaguchi T, Hori T, Kamada A, Kondo T, Ito M, Odawara T, Hirayasu Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):755-60. PubMed ID: 18226436
    [Abstract] [Full Text] [Related]

  • 3. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.
    Kim JH, Kim SY, Ahn YM, Kim YS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar 01; 30(2):301-5. PubMed ID: 16309807
    [Abstract] [Full Text] [Related]

  • 4. Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride.
    Linden M, Scheel T, Eich FX.
    J Psychopharmacol; 2006 Nov 01; 20(6):815-23. PubMed ID: 16401647
    [Abstract] [Full Text] [Related]

  • 5. Subjective experience and subjective response to neuroleptics in schizophrenia.
    Rossi A, Arduini L, Stratta P, Pallanti S.
    Compr Psychiatry; 2000 Nov 01; 41(6):446-9. PubMed ID: 11086150
    [Abstract] [Full Text] [Related]

  • 6. [Therapeutic treatment with neuroleptics. II: Subjective mechanisms of effect, compliance and consequences for treatment strategy].
    Krausz M, Sorgenfrei T.
    Psychiatr Prax; 1991 Jan 01; 18(1):14-20. PubMed ID: 1674155
    [Abstract] [Full Text] [Related]

  • 7. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
    Hofer A, Rettenbacher MA, Edlinger M, Kemmler G, Widschwendter CG, Fleischhacker WW.
    Acta Psychiatr Scand; 2007 Nov 01; 116(5):354-61. PubMed ID: 17868428
    [Abstract] [Full Text] [Related]

  • 8. Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance.
    Lambert M, Schimmelmann BG, Karow A, Naber D.
    Pharmacopsychiatry; 2003 Nov 01; 36 Suppl 3():S181-90. PubMed ID: 14677077
    [Abstract] [Full Text] [Related]

  • 9. [Relationships between positive or negative early subjective response to antipsychotics and demographic and clinical variables in the group of patients with schizophrenia].
    Murawiec S.
    Psychiatr Pol; 2005 Nov 01; 39(6):1185-98. PubMed ID: 16526184
    [Abstract] [Full Text] [Related]

  • 10. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM, Kluge M, Schneider E, Schacht A, Wagner T, Schreiber W.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr 13; 31(3):703-12. PubMed ID: 17289237
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV, Clark E, Lu S.
    J Adv Nurs; 2009 Mar 13; 65(3):534-43. PubMed ID: 19222651
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV, Brown WA, Laughren TP.
    J Clin Psychiatry; 1987 Apr 13; 48(4):151-4. PubMed ID: 2881923
    [Abstract] [Full Text] [Related]

  • 16. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z, Britvić D, Vuković O, Ille T.
    Psychiatr Danub; 2008 Mar 13; 20(1):42-52. PubMed ID: 18376330
    [Abstract] [Full Text] [Related]

  • 17. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, Izaki Y, Tayoshi S, Kinouchi S, Sumitani S, Tayoshi S, Takikawa Y, Kaneda Y, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T.
    Psychiatry Clin Neurosci; 2008 Aug 13; 62(4):404-11. PubMed ID: 18778437
    [Abstract] [Full Text] [Related]

  • 18. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B, Nemoto T, Fujii C, Mizuno M.
    Psychiatry Clin Neurosci; 2009 Aug 13; 63(4):521-8. PubMed ID: 19531107
    [Abstract] [Full Text] [Related]

  • 19. How antipsychotics work: the patients' perspective.
    Mizrahi R, Bagby RM, Zipursky RB, Kapur S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun 13; 29(5):859-64. PubMed ID: 15908094
    [Abstract] [Full Text] [Related]

  • 20. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA, Knegtering H, van den Bosch RJ, Wiersma D.
    Schizophr Res; 2009 Jul 13; 112(1-3):114-8. PubMed ID: 19395241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.